TOR1A, THAP1, and GNAL mutational screening in Austrian patients with primary isolated dystonia

Mov Disord. 2015 Nov;30(13):1853-4. doi: 10.1002/mds.26458. Epub 2015 Oct 28.

Authors

Michael Zech^{1

2}, Sylvia Boesch³, Thomas Sycha⁴, Joerg Mueller^{3

5}, Werner Poewe³, Juliane Winkelmann^{1

2

6}

Affiliations

¹ Neurologische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
² Institut für Neurogenomik, Helmholtz Zentrum München, Munich, Germany.
³ Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
⁴ Department of Neurology, Medical University Vienna, Vienna, Austria.
⁵ Vivantes Klinikum Spandau, Berlin, Germany.
⁶ Munich Cluster for Systems Neurology, SyNergy, Munich, Germany.

PMID: 26506956
DOI: 10.1002/mds.26458

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Apoptosis Regulatory Proteins / genetics*
Austria
DNA Mutational Analysis
DNA-Binding Proteins / genetics*
Dystonic Disorders / genetics*
Female
GTP-Binding Protein alpha Subunits / genetics*
Humans
Male
Molecular Chaperones / genetics*
Mutation / genetics*
Nuclear Proteins / genetics*

Substances

Apoptosis Regulatory Proteins
DNA-Binding Proteins
GTP-Binding Protein alpha Subunits
Molecular Chaperones
Nuclear Proteins
THAP1 protein, human
TOR1A protein, human
olfactory G protein subunit alpha olf